RPS6 and medullary thyroid gland carcinoma: Activation of the mTOR pathway was previously demonstrated in human primary MTC and lymph node metastasis, whereby phosphorylation of S6, a downstream target of mTORC1, was evident in 96% of MTC samples 49.